New hope for advanced cancer patients? early trial of ZE94-0605 begins
Disease control
Recruiting now
This early-phase study tests an experimental drug called ZE94-0605 in about 60 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and check for any signs of tumor shrinkage. The study is not yet recruiting.
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC